CN107913400A - 一种治疗急性腹膜炎的中西药组合物及制备方法 - Google Patents
一种治疗急性腹膜炎的中西药组合物及制备方法 Download PDFInfo
- Publication number
- CN107913400A CN107913400A CN201710029513.9A CN201710029513A CN107913400A CN 107913400 A CN107913400 A CN 107913400A CN 201710029513 A CN201710029513 A CN 201710029513A CN 107913400 A CN107913400 A CN 107913400A
- Authority
- CN
- China
- Prior art keywords
- chinese
- western
- root
- medicinal composition
- herb
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 206010034674 peritonitis Diseases 0.000 title claims abstract description 42
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 239000003814 drug Substances 0.000 claims abstract description 37
- 239000002994 raw material Substances 0.000 claims abstract description 21
- 244000145591 rattan cane Species 0.000 claims abstract description 19
- 235000012950 rattan cane Nutrition 0.000 claims abstract description 19
- 240000004784 Cymbopogon citratus Species 0.000 claims abstract description 18
- 235000017897 Cymbopogon citratus Nutrition 0.000 claims abstract description 18
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 18
- 235000008397 ginger Nutrition 0.000 claims abstract description 18
- 244000205574 Acorus calamus Species 0.000 claims abstract description 17
- 235000011996 Calamus deerratus Nutrition 0.000 claims abstract description 17
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 17
- 241000723346 Cinnamomum camphora Species 0.000 claims abstract description 17
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims abstract description 17
- 241001313868 Arundina Species 0.000 claims abstract description 16
- DKMVJQCQTCLYIF-UHFFFAOYSA-M Methylbenactyzium bromide Chemical compound [Br-].C=1C=CC=CC=1C(O)(C(=O)OCC[N+](C)(CC)CC)C1=CC=CC=C1 DKMVJQCQTCLYIF-UHFFFAOYSA-M 0.000 claims abstract description 16
- 241000274183 Micromeria Species 0.000 claims abstract description 16
- 241000843353 Embelia Species 0.000 claims abstract description 15
- 102000016943 Muramidase Human genes 0.000 claims abstract description 13
- 108010014251 Muramidase Proteins 0.000 claims abstract description 13
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract description 13
- 229960000274 lysozyme Drugs 0.000 claims abstract description 13
- 235000010335 lysozyme Nutrition 0.000 claims abstract description 13
- 239000004325 lysozyme Substances 0.000 claims abstract description 13
- 239000004480 active ingredient Substances 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 241000723353 Chrysanthemum Species 0.000 claims description 16
- 241001092070 Eriobotrya Species 0.000 claims description 16
- 241000234314 Zingiber Species 0.000 claims description 16
- 239000000843 powder Substances 0.000 claims description 15
- 241000894006 Bacteria Species 0.000 claims description 7
- 239000012153 distilled water Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 230000008030 elimination Effects 0.000 claims description 4
- 238000003379 elimination reaction Methods 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 238000007796 conventional method Methods 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 3
- 238000007731 hot pressing Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 235000021419 vinegar Nutrition 0.000 claims description 3
- 239000000052 vinegar Substances 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims 3
- 102000004190 Enzymes Human genes 0.000 claims 3
- 229940088598 enzyme Drugs 0.000 claims 3
- 241000233855 Orchidaceae Species 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 15
- 210000002784 stomach Anatomy 0.000 abstract description 15
- 210000000952 spleen Anatomy 0.000 abstract description 12
- 230000000968 intestinal effect Effects 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 7
- 208000011580 syndromic disease Diseases 0.000 abstract description 5
- 230000001079 digestive effect Effects 0.000 abstract description 4
- 241000193830 Bacillus <bacterium> Species 0.000 abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 3
- 239000002260 anti-inflammatory agent Substances 0.000 abstract description 3
- 230000001741 anti-phlogistic effect Effects 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 238000002560 therapeutic procedure Methods 0.000 abstract description 3
- 244000273928 Zingiber officinale Species 0.000 abstract description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 244000061508 Eriobotrya japonica Species 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 14
- 210000001015 abdomen Anatomy 0.000 description 11
- 208000004998 Abdominal Pain Diseases 0.000 description 9
- 206010047700 Vomiting Diseases 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- CAOOISJXWZMLBN-PPHPATTJSA-N htn0d03vrz Chemical compound Cl.C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 CAOOISJXWZMLBN-PPHPATTJSA-N 0.000 description 6
- 238000007689 inspection Methods 0.000 description 6
- 230000008673 vomiting Effects 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010036790 Productive cough Diseases 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 238000011084 recovery Methods 0.000 description 5
- 208000024794 sputum Diseases 0.000 description 5
- 210000003802 sputum Anatomy 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 206010000269 abscess Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 238000003304 gavage Methods 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010000097 Abdominal tenderness Diseases 0.000 description 3
- 206010008631 Cholera Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010028813 Nausea Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 210000003489 abdominal muscle Anatomy 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 230000008693 nausea Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 208000005577 Gastroenteritis Diseases 0.000 description 2
- 208000010412 Glaucoma Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010061481 Renal injury Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 208000012873 acute gastroenteritis Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 201000001352 cholecystitis Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 208000007784 diverticulitis Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 208000027692 gas pain Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 208000003265 stomatitis Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000009278 visceral effect Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000007743 Acute Abdomen Diseases 0.000 description 1
- 208000000197 Acute Cholecystitis Diseases 0.000 description 1
- 208000010470 Ageusia Diseases 0.000 description 1
- 241000224489 Amoeba Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008614 Cholecystitis acute Diseases 0.000 description 1
- 206010009900 Colitis ulcerative Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 244000168525 Croton tiglium Species 0.000 description 1
- 206010063057 Cystitis noninfective Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241001248531 Euchloe <genus> Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 206010061207 Hernia obstructive Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028372 Muscular weakness Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- WXOMTJVVIMOXJL-BOBFKVMVSA-A O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O Chemical compound O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)OS(=O)(=O)OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O WXOMTJVVIMOXJL-BOBFKVMVSA-A 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 206010034236 Pelvic abscess Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010037294 Puerperal pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000007893 Salpingitis Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010056349 Subdiaphragmatic abscess Diseases 0.000 description 1
- 208000003144 Subphrenic Abscess Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044248 Toxic shock syndrome Diseases 0.000 description 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 201000006704 Ulcerative Colitis Diseases 0.000 description 1
- 206010047697 Volvulus Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000012084 abdominal surgery Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 230000010398 acute inflammatory response Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003591 anti-choleraic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000037902 enteropathy Diseases 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 210000005086 glomerual capillary Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000008384 ileus Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 201000008267 intestinal tuberculosis Diseases 0.000 description 1
- 201000007647 intestinal volvulus Diseases 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 208000037806 kidney injury Diseases 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 210000000505 parietal peritoneum Anatomy 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01017—Lysozyme (3.2.1.17)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Emergency Medicine (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗急性腹膜炎的中西药组合物及制备方法,制成所述中西药组合物有效成分的原料组成为:白菖、长杆兰、姜味草、杯菊、地枇杷、良藤、酸藤木、香茅、橘皮、香樟根、生姜、黑皮根、溶菌酶、甲溴贝那替秦;本发明中西药组合物将中医和西医疗法相结合,具有杀菌消炎、清热解毒、祛风利湿、补益脾胃、散寒解表、温中止痛和辟秽和中的功效,并能够消除肠道有害细菌,有助于肠道正常菌群的生长,改善消化功能,调节全身免疫力,对急性腹膜炎疗效确切,见效快,在选方上,本发明用于治疗急性腹膜炎具有一定创新性,具有一定的社会经济价值。
Description
技术领域
本发明涉及医药技术领域,特别涉及一种治疗急性腹膜炎的中西药组合物及制备方法。
背景技术
急性腹膜炎是常见的外科急腹症,其病理基础是腹膜壁层和(或)脏层因各种原因受到刺激或损害发生急性炎性反应,多由细菌感染,化学刺激或物理损伤所引起。大多数为继发性腹膜炎,源于腹腔的脏器感染,坏死穿孔、外伤等。
其典型临床表现为腹膜炎三联征-腹部压痛、腹肌紧张和反跳痛,以及腹痛、恶心,呕吐,发烧,白血球升高等,严重时可致血压下降和全身中毒性反应,如未能及时治疗可死于中毒性休克。部分病人可并发盆腔脓肿,肠间脓肿和膈下脓肿,髂窝脓肿、及粘连性肠梗阻等并发症。
急性腹膜炎分为继发性腹膜炎和原发性腹膜炎。
继发性腹膜炎发病原因:
⑴腹内脏器的急性穿孔与破裂:是急性继发性腹膜炎最常见的原因。空腔脏器穿孔往往因溃疡或坏疽性病变进展而突然发生,例如,急性阑尾炎、消化性溃疡、急性胆囊炎、伤寒溃疡、胃或结肠癌、溃疡性结肠炎、溃疡性肠结核、阿米巴肠病、憩室炎等穿孔而导致急性腹膜炎。实质脏器例如肝、脾,也可因脓肿或癌肿而发生破裂。
⑵腹内脏器急性感染的扩散:例如急性阑尾炎、胆囊炎、胰腺炎、憩室炎、女性生殖道上升性感染(如产褥热、输卵管炎)等,可蔓延至腹膜引起急性炎症。
⑶急性肠梗阻:肠套叠、肠扭转、嵌顿性疝、肠系膜血管栓塞或血栓形成等引起绞窄性肠梗阻后,因肠壁损伤,失去正常的屏障作用,肠内细菌可经肠壁侵入腹腔,产生腹膜炎。
⑷腹部外科情况:利器、子弹穿通腹壁时,可穿破空腔脏器,或将外界细菌引入腹腔,腹部撞伤有时也可使内脏破裂,产生急性腹膜炎。腹部手术时,可由于消毒不严,而将外面细菌带至腹腔;也可因手术不慎,使局部的感染扩散,或胃、肠、胆、胰的缝合口溢漏,有时由于腹腔穿刺放液或作腹膜透析时忽视无菌操作,均可造成急性腹膜炎的后果。
原发性腹膜炎发病原因:
原发性腹膜炎又称自发性腹膜炎,腹腔内无原发病灶。致病菌多为溶血性链球菌、肺炎双球菌或大肠杆菌。
目前,治疗急性腹膜炎的方法有药物治疗和手术治疗,其中药物治疗多为西药,但长期使用西药会产生耐药性,另外,也有一些中药,然而这些中药治疗时间长;手术治疗花费高、痛苦大。
发明内容
本发明提供了一种治疗急性腹膜炎的中西药组合物及制备方法;本发明中西药组合物将中医和西医疗法相结合,具有杀菌消炎、清热解毒、祛风利湿、补益脾胃、散寒解表、温中止痛和辟秽和中的功效,并能够消除肠道有害细菌,有助于肠道正常菌群的生长,改善消化功能,调节全身免疫力,对急性腹膜炎疗效确切,见效快,在选方上,本发明用于治疗急性腹膜炎具有一定创新性,具有一定的社会经济价值。
为实现上述目的,本发明的技术方案实施如下:
一种治疗急性腹膜炎的中西药组合物,制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:白菖45-57g、长杆兰38-50g、姜味草38-50g、杯菊35-47g、地枇杷32-44g、良藤25-37g、酸藤木25-37g、香茅23-35g、橘皮20-28g、香樟根13-18g、生姜13-18g、黑皮根9-15g;所述西药组分由以下重量数的原料配制而成:溶菌酶1-10mg、甲溴贝那替秦1-10mg。
制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由
以下重量数的原料配制而成:白菖54g、长杆兰47g、姜味草47g、杯菊44g、地枇杷41g、良藤34g、酸藤木34g、香茅32g、橘皮26g、香樟根16g、生姜16g、黑皮根13g;所述西药组分由以下重量数的原料配制而成:溶菌酶7mg、甲溴贝那替秦7mg。
制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:白菖51g、长杆兰44g、姜味草44g、杯菊41g、地枇杷38g、良藤31g、酸藤木31g、香茅29g、橘皮24g、香樟根15g、生姜15g、黑皮根11g;所述西药组分由以下重量数的原料配制而成:溶菌酶5mg、甲溴贝那替秦5mg。
制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:白菖48g、长杆兰41g、姜味草41g、杯菊38g、地枇杷35g、良藤28g、酸藤木28g、香茅26g、橘皮22g、香樟根14g、生姜14g、黑皮根10g;所述西药组分由以下重量数的原料配制而成:溶菌酶3mg、甲溴贝那替秦3mg。
一种治疗急性腹膜炎的中西药组合物的制备方法,包括以下工艺步骤:
(1)将白菖、姜味草和杯菊浸入米醋溶液2-3小时,取出洗净,低温干燥,研末,得到过160目的细粉,备用;
(2)将长杆兰、地枇杷、良藤、酸藤木、香茅、橘皮、香樟根和黑皮根加水煎煮2次,第一次加入10-20倍量水,第二次加入8-15倍量水,每次3-5小时,合并二次煎液,300目筛网滤过,滤液减压浓缩至80℃时所测相对密度为1.05-1.15的浸膏,然后干燥,粉碎,过100-200目筛,得浸膏粉,备用;
(3)将生姜捣烂,压榨取汁,静置,分取沉淀的粉质,微波烘干,研末,得到过180目的细粉,备用;
(4)将溶菌酶和甲溴贝那替秦放入容器中,加入5-8倍的蒸馏水搅拌均匀,过滤,去杂质,取溶液备用;
(5)将上述所得的细粉、浸膏粉和溶液混合,加入10倍量的蒸馏水,在121
℃热压下灭菌30分钟,按常规方法制成0.4g/片的片剂,密封包装,即为所述的治疗急性腹膜炎的中西药组合物。
本发明所用中药的药性如下:
白菖:味苦、辛,性温。化痰,开窍,健脾,利湿。治癫痫,惊悸健忘,神志不请,湿滞痞胀,泄泻痢疾,风湿疼痛,痈肿疥疮。《上海常用中草药》载:“镇静安神,化痰,健胃。治癫痫,耳鸣,听觉不灵,胸腹胀闷。”
长杆兰:味苦,性微寒;归肝、肾、膀胱经。清热解毒。祛风利湿。主热淋,黄疸,水肿,脚气浮肿,疝气腹痛,风湿痹痛,毒蛇咬伤,疮痈肿毒,跌打损伤。《广西药植名录》载:“止痛,散瘀,利水。治痧气,积热,浮肿,腹痛,疳积,黄疸,肺结核,精神病,风湿骨痛,刀伤出血,蛇伤。”
姜味草:味苦、辛,性温。散寒解表,湿中健胃,化湿消积。主风寒感冒,胃寒脘痛,腹胀,恶心呕吐,泄泻,痢疾,症瘕,寒疝。《滇南本草》载:“燥脾暖胃,进饮食,宽中下气。疗九种胃气疼痛,面寒痛,胸膈气胀,肚腹冷痛,呕吐恶心,噎膈翻胃,五积六聚,痞块疼痛,男子寒疝疼,妇人症瘕成痛。”
杯菊:味苦,性凉。清热解毒,消炎止血,除湿利尿,杀虫。主治急性胃肠炎,中暑,膀胱炎,尿道炎,咽喉炎,口腔炎,吐血,衄血。
地枇杷:味苦、微甘,性平。清热利湿。用于小儿消化不良,急性肠胃炎,痢疾,胃、十二指肠溃疡,尿路感染,白带,感冒,咳嗽,风湿筋骨疼痛。
良藤:味苦,性寒。清热解毒,散瘀止痛,利尿通淋。主外感风热,咳嗽,咽喉肿痛,湿热泻痢,牙痛,跌打伤痛,小便淋涩。
酸藤木:味酸、涩,性凉。清热解毒,散瘀止血。主咽喉红肿,齿龈出血,痢疾,泄泻,疮疖溃疡,皮肤瘙痒,痔疮肿痛,跌打损伤。《陆川本草》载:“消炎,杀菌。治口腔炎,喉炎,牙龈炎、疮疖溃疡等。并解大茶药毒、木茹毒、巴豆毒。”
香茅:味辛、温,性甘。祛风通络,温中止痛,止泻。主感冒头身疼痛,风寒湿痹,脘腹冷痛,泄泻,跌打损伤。《岭南采药录》载:“散跌打伤瘀血,通经
络。头风痛,以之煎水洗。将香茅与米同炒,加水煎饮,止水泻。煎水洗身,可祛风消肿,解腥臭。提取其油,可止腹痛。”
橘皮:味辛、苦,性温;归脾、肺经。理气,调中,燥湿,化痰。治胸腹胀满,不思饮食,呕吐哕逆,咳嗽痰多。亦解鱼、蟹毒。《别录》载:“下气,止呕咳,除膀胱留热、停水、五琳,利小便,主脾不能消谷,气冲胸中,吐逆霍乱,止泄,去寸白。”现代医学研究证实,橘皮具有抗炎、抗溃疡和利胆作用。
香樟根:味辛,性温;归肝、脾经。温中止痛,辟秽和中,祛风除湿。主胃脘疼痛,霍乱吐泻,风湿痹痛,皮肤瘙痒。《分类草药性》载:“治一切气痛,理痹,顺气,并霍乱呕吐。”
生姜:味辛,性温;归肺、胃、脾经。散寒解表,降逆止呕,化痰止咳。主风寒感冒,恶寒发热,头痛鼻塞,呕吐,痰饮喘咳,胀满,泄泻。《珍珠囊》载:“益脾胃,散风寒。”
黑皮根:味甘,性平;归脾、胃、肾经。补益脾胃,滋肾固精。主慢性胃炎,脾胃亏损,食欲不振,四肢无力,遗精。
本发明与现有技术相比,具有以下有益效果:
本发明中西药组合物将中医和西医疗法相结合,具有杀菌消炎、清热解毒、祛风利湿、补益脾胃、散寒解表、温中止痛和辟秽和中的功效,并能够消除肠道有害细菌,有助于肠道正常菌群的生长,改善消化功能,调节全身免疫力,对急性腹膜炎疗效确切,见效快,在选方上,本发明用于治疗急性腹膜炎具有一定创新性,具有一定的社会经济价值。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明中西药组合物有效成分的原料组成及重量为:白菖56g、长杆兰48g、姜味草48g、杯菊46g、地枇杷43g、良藤36g、酸藤木36g、香茅33g、橘皮27g、香樟根17g、生姜17g、黑皮根14g、溶菌酶9mg、甲溴贝那替秦9mg。
本发明中西药组合物的制备方法,包括以下工艺步骤:
(1)将白菖、姜味草和杯菊浸入米醋溶液2-3小时,取出洗净,低温干燥,研末,得到过160目的细粉,备用;
(2)将长杆兰、地枇杷、良藤、酸藤木、香茅、橘皮、香樟根和黑皮根加水煎煮2次,第一次加入10-20倍量水,第二次加入8-15倍量水,每次3-5小时,合并二次煎液,300目筛网滤过,滤液减压浓缩至80℃时所测相对密度为1.05-1.15的浸膏,然后干燥,粉碎,过100-200目筛,得浸膏粉,备用;
(3)将生姜捣烂,压榨取汁,静置,分取沉淀的粉质,微波烘干,研末,得到过180目的细粉,备用;
(4)将溶菌酶和甲溴贝那替秦放入容器中,加入5-8倍的蒸馏水搅拌均匀,过滤,去杂质,取溶液备用;
(5)将上述所得的细粉、浸膏粉和溶液混合,加入10倍量的蒸馏水,在121℃热压下灭菌30分钟,按常规方法制成0.4g/片的片剂,密封包装,即为所述的治疗急性腹膜炎的中西药组合物。
用法用量:口服,每日2次,每次2片(每片0.4g),饭后温开水送服,3天为一疗程,2到5个疗程即可痊愈,病情严重者遵医嘱酌增用量,孕妇、青光眼患者禁用。
实施例2
本发明中西药组合物有效成分的原料组成及重量为:白菖54g、长杆兰47g、姜味草47g、杯菊44g、地枇杷41g、良藤34g、酸藤木34g、香茅32g、橘皮26g、香樟根16g、生姜16g、黑皮根13g、溶菌酶7mg、甲溴贝那替秦7mg。
本实施例中西药组合物制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明中西药组合物有效成分的原料组成及重量为:白菖51g、长杆兰44g、姜味草44g、杯菊41g、地枇杷38g、良藤31g、酸藤木31g、香茅29g、橘皮24g、香樟根15g、生姜15g、黑皮根11g、溶菌酶5mg、甲溴贝那替秦5mg。
本实施例中西药组合物制备方法工艺步骤及用法用量与实施例1相同。
实施例4
本发明中西药组合物有效成分的原料组成及重量为:白菖48g、长杆兰41g、姜味草41g、杯菊38g、地枇杷35g、良藤28g、酸藤木28g、香茅26g、橘皮22g、香樟根14g、生姜14g、黑皮根10g、溶菌酶3mg、甲溴贝那替秦3mg。
本实施例中西药组合物制备方法工艺步骤及用法用量与实施例1相同。
实验部分(动物急性毒性试验):
1、实验材料:实验动物为健康小鼠,雌雄各半,体重24±1g,每组20只小鼠。实验药物选用本发明中西药组合物、盐酸左氧氟沙星胶囊。实验材料选用ALT测定试剂盒。
2、方法:
实验组:取本发明中西药组合物1片溶解在10ml水中,对小鼠进行灌胃,灌胃容积为10ml/kg,早晚各一次,共4天。
对照组:取盐酸左氧氟沙星胶囊1片溶解在10ml水中,对小鼠进行灌胃,灌胃容积为10ml/kg,早晚各一次,共4天。
空白组:服用相同量的生理盐水,早晚各一次,共4天。
3、检测及检测结果:
(1)、肝脏损伤检测:4天后,小鼠眼眶取血,分离血清。测定血清ALT活性。
结果:盐酸左氧氟沙星胶囊对照组小鼠血清ALT活性明显高于试验组。
讨论:根据以上实验结果可知,与常规药物盐酸左氧氟沙星胶囊相比,本申请中的中西药组合物可极大降低对肝脏损伤程度。
(2)、肾脏损伤检测:光镜检查。
结果:对照组肾组织光镜检查可见肾小球毛细血管基底膜弥漫性增厚,肾小球增大,基质增多。实验组和空白组小鼠肾小球及小管间质未见明显的病理改变。
讨论:根据以上实验结果可知,与常规药物盐酸左氧氟沙星胶囊相比,本申
请中的中西药组合物可以极大降低对肾脏的损伤程度。
临床资料:
1、病例选择:
选择急性腹膜炎的患者220例临床观察,病人随机分成治疗组和对照组,治疗组110例,其中男性55例,女性55例,年龄18-74岁,平均年龄53.1岁,病程1天-1周;对照组110例,其中男性55例,女性55例,年龄18-75岁,平均年龄52.7岁,病程1天-1周;两组病例的病程、症状轻重程度基本一致,无显著差异,具有可比性。
2、药物选择:
治疗组患者服用本发明中西药组合物,口服,每日2次,每次2片(每片0.4g),饭后温开水送服,3天为一疗程,2到5个疗程即可痊愈,病情严重者遵医嘱酌增用量,孕妇、青光眼患者禁用。
对照组服用盐酸左氧氟沙星胶囊,按说明书用,病情严重者遵医嘱酌增用量。
3、疗效判定:
(1)治愈:腹部压痛、腹肌紧张、反跳痛、腹痛、恶心、呕吐、发烧、白血球升高等症状消失,身体恢复正常。
(2)有效:上述症状有所缓解。
(3)无效:病症无变化。
4、结果:
以上结果显示,治疗组治愈率和总有效率明显高于对照组。
典型病例举例:
1、王某,男,66岁,退休干部。患者6年前出现中上腹部绞痛,来我院就
诊,经检查确诊为急性腹膜炎。给予服用本发明中西药组合物5天,疼痛好转;继续服用本发明中西药组合物8天,身体恢复正常,随访未复发,彻底治愈。
2、刘某,女,60岁,务农。患者2年前无明显诱因出现腹痛,在当地诊所给予药物治疗后加重,来我院就诊,经检查确诊为急性腹膜炎。给予服用本发明中西药组合物5天,上述症状好转;继续服用本发明中西药组合物10天,上述症状消失,身体恢复正常,随访未复发,彻底治愈。
3、童某,男,55岁,公务员。患者大量饮酒后出现剧烈腹痛、恶心、呕吐等症状,遂来我院就诊,经检查确诊为急性腹膜炎。给予服用本发明中西药组合物2天,上述症状好转;继续服用本发明中西药组合物8天,上述症状消失,随访未复发,彻底治愈。
4、胡某,女,49岁,个体户。患者无明显诱因出现腹痛、腹部压痛、腹肌紧张和反跳痛,在当地医院治疗后无果。后来我院就诊,经检查确诊为急性腹膜炎。给予服用本发明中西药组合物4天,上述症状好转;继续服用本发明中西药组合物5天,上述症状全部消失,身体痊愈,随访未复发,彻底治愈。
5、郭某,男,36岁,业务员。患者2年前无明显诱因出现腹痛、腹胀,以下腹及脐周明显,呈阵发性加重,遂来我院就诊,经检查确诊为急性腹膜炎。给予服用本发明中西药组合物3天,上述症状好转;继续服用本发明中西药组合物9天,上述症状全部消失,身体痊愈,随访未复发,彻底治愈。
6、韩某,女,22岁,学生。患者出现腹痛、腹胀、恶心等症状,来我院就诊,经检查确诊为急性腹膜炎。给予服用本发明中西药组合物9天,上述症状全部消失,身体恢复正常,随访未复发,彻底治愈。
Claims (5)
1.一种治疗急性腹膜炎的中西药组合物,其特征在于:制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:白菖45-57g、长杆兰38-50g、姜味草38-50g、杯菊35-47g、地枇杷32-44g、良藤25-37g、酸藤木25-37g、香茅23-35g、橘皮20-28g、香樟根13-18g、生姜13-18g、黑皮根9-15g;所述西药组分由以下重量数的原料配制而成:溶菌酶1-10mg、甲溴贝那替秦1-10mg。
2.根据权利要求1所述的一种治疗急性腹膜炎的中西药组合物,其特征在于:制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:白菖54g、长杆兰47g、姜味草47g、杯菊44g、地枇杷41g、良藤34g、酸藤木34g、香茅32g、橘皮26g、香樟根16g、生姜16g、黑皮根13g;所述西药组分由以下重量数的原料配制而成:溶菌酶7mg、甲溴贝那替秦7mg。
3.根据权利要求1所述的一种治疗急性腹膜炎的中西药组合物,其特征在于:制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:白菖51g、长杆兰44g、姜味草44g、杯菊41g、地枇杷38g、良藤31g、酸藤木31g、香茅29g、橘皮24g、香樟根15g、生姜15g、黑皮根11g;所述西药组分由以下重量数的原料配制而成:溶菌酶5mg、甲溴贝那替秦5mg。
4.根据权利要求1所述的一种治疗急性腹膜炎的中西药组合物,其特征在于:制成所述中西药组合物有效成分包括中药组分和西药组分,所述中药组分由以下重量数的原料配制而成:白菖48g、长杆兰41g、姜味草41g、杯菊38g、地枇杷35g、良藤28g、酸藤木28g、香茅26g、橘皮22g、香樟根14g、生姜14g、黑皮根10g;所述西药组分由以下重量数的原料配制而成:溶菌酶3mg、甲溴贝那替秦3mg。
5.一种如权利要求1-4任一项所述的治疗急性腹膜炎的中西药组合物的制备方法,其特征在于:包括以下步骤:
(1)将白菖、姜味草和杯菊浸入米醋溶液2-3小时,取出洗净,低温干燥,研末,得到过160目的细粉,备用;
(2)将长杆兰、地枇杷、良藤、酸藤木、香茅、橘皮、香樟根和黑皮根加水煎煮2次,第一次加入10-20倍量水,第二次加入8-15倍量水,每次3-5小时,合并二次煎液,300目筛网滤过,滤液减压浓缩至80℃时所测相对密度为1.05-1.15的浸膏,然后干燥,粉碎,过100-200目筛,得浸膏粉,备用;
(3)将生姜捣烂,压榨取汁,静置,分取沉淀的粉质,微波烘干,研末,得到过180目的细粉,备用;
(4)将溶菌酶和甲溴贝那替秦放入容器中,加入5-8倍的蒸馏水搅拌均匀,过滤,去杂质,取溶液备用;
(5)将上述所得的细粉、浸膏粉和溶液混合,加入10倍量的蒸馏水,在121℃热压下灭菌30分钟,按常规方法制成0.4g/片的片剂,密封包装,即为所述的治疗急性腹膜炎的中西药组合物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710029513.9A CN107913400A (zh) | 2017-01-16 | 2017-01-16 | 一种治疗急性腹膜炎的中西药组合物及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710029513.9A CN107913400A (zh) | 2017-01-16 | 2017-01-16 | 一种治疗急性腹膜炎的中西药组合物及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107913400A true CN107913400A (zh) | 2018-04-17 |
Family
ID=61898582
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710029513.9A Withdrawn CN107913400A (zh) | 2017-01-16 | 2017-01-16 | 一种治疗急性腹膜炎的中西药组合物及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107913400A (zh) |
-
2017
- 2017-01-16 CN CN201710029513.9A patent/CN107913400A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102613566B (zh) | 一种用于润肠通便的保健品及其制备方法 | |
CN105166545A (zh) | 一种牛配合饲料及其制备方法 | |
CN107095995B (zh) | 一种治疗胃炎和胃溃疡的药物组合物及制备方法 | |
CN103463584A (zh) | 治疗消化性溃疡的中药组合物及其制备方法 | |
CN105028995A (zh) | 一种配合狗粮及其制备方法 | |
CN105535495B (zh) | 一种培元固本治疗食管癌的中药组合物及制备方法 | |
CN103989955A (zh) | 一种治疗胃、十二指肠溃疡、浅表性多发性胃溃疡、糜烂性胃溃疡的药物组合物 | |
KR20050101942A (ko) | 알레르기성 비염과 감기의 예방 및 치료용 건강식품조성물 및 그 제조 방법 | |
CN104524481B (zh) | 一种治疗肠易激综合征的中药及其制备方法 | |
CN105232764A (zh) | 一种治疗胃绞痛、胆囊绞痛、胆汁倒流引起疼痛的藏药复方藏药制剂 | |
CN104857454B (zh) | 一种治疗重症急性胰腺炎的中药汤剂 | |
CN108042669A (zh) | 一种治疗风火牙痛的中药及其制作方法 | |
KR20140093461A (ko) | 음용감이 우수한 소화기능 개선용 민트명수액 및 그 제조 방법 | |
CN102178866A (zh) | 用于气郁、血瘀体质人袪湿活血、软坚散结的中药制剂及其制备方法和应用 | |
CN105168522A (zh) | 医治腹胀的药剂及制法 | |
CN107913400A (zh) | 一种治疗急性腹膜炎的中西药组合物及制备方法 | |
CN104096159B (zh) | 缓解慢性痢疾及肠功能紊乱的活菌合剂及其制备方法 | |
CN104435744A (zh) | 一种治疗功能性消化不良的中药稠膏及制法 | |
CN103705692B (zh) | 一种治疗急性胃肠炎的中药制剂 | |
CN108030835A (zh) | 一种快速治疗牙龈肿痛的中药及其制作方法 | |
CN108042668A (zh) | 一种治疗风火牙痛的中药及其制作方法 | |
CN107998230A (zh) | 一种治疗牙龈肿痛的中药及其制作方法 | |
CN107913402A (zh) | 一种治疗萎缩性胃炎的中西医结合药物及制备方法 | |
CN106237245B (zh) | 一种治疗急慢性腹泻的中药组合物及其制剂和应用 | |
CN111406921A (zh) | 一种药食同源养护胃肠食品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20180417 |